Nat Med 8(7):738742 Ggebakan , Andres J, Biedasek K et al (2012) Glucose-dependent insulinotropic polypeptide reduces fat-specific expression and activity of 11-hydroxysteroid dehydrogenase type 1 and inhibits release of free fatty acids
Funding Support for this work was provided by US National Institutes of Health grants R56DK123738 and R01DK123738 to E.E.S
Tirzepatide Added to Restricted Drug List Following a review of the clinical use of Injectable GLP-1 Receptor Agonists for obesity and Type-2 Diabetes Mellitus, the Ministry has approved the inclusion of Injection Tirzepatide (Mounjaro) in the CGHS Online List of Restricted Drugs
Lipo-C (The Advanced Fat Burner): The Lipo-C shot includes the entire MIC B12 formula but is supercharged with L-Carnitine, B-Complex, and Vitamin C
= exceeds 28-day window per reconstitution Solution: If you're running maintenance only, reconstitute in two batches (add less water the second time) or plan a short loading phase to use the first batch within 28 days
Presented for research literature review only Deponte M et al